To test new drugs and treatments for ALS/MND, researchers and pharmaceutical companies must perform clinical trials. A clinical trial is a therapeutic or observational research study to test whether a new drug or therapy is safe and effective for use in humans. Prior to any clinical trial, a drug must pass through a series of steps. See our Drug Pathways page to learn more about the approval phases of drugs or therapies.
For ALS/MND, there are many potential drugs and therapies currently undergoing clinical trials. Clinical trials are essential to new drug approvals. However, enrollment in a clinical trial should always be voluntary. People living with ALS/MND must consent prior to enrollment and have the right to know all pertinent details surrounding the trial.
Clinical Trial Databases
The International Alliance of ALS/MND Associations provides information on drugs and therapies currently being researched. In addition, the resources below, contain databases of known clinical trials for ALS/MND. These resources may be used to stay up to date on clinical trials for ALS/MND, as well as for people living with ALS/MND who are interested in enrolling in a clinical trial.
ALS Clinical Trials – ALS TDI
Italy’s First Live ALS International Clinical Trial Database